Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam-based sedation for large-area liposuction
ChiCTR2200062292Phase 4Completed
- Sponsor
- Department of Anesthesiology, Plastic Surgery Hospital of Chinese Academy of Medical Sciences
- Start
- Jun 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam, dexmedetomidine and remifentanil in localized adiposity (AL) (2 arms), sponsored by Department of Anesthesiology, Plastic Surgery Hospital of Chinese Academy of Medical Sciences. Primary endpoint: Patient satisfaction and surgeon satisfaction scores. Started Jun 2022; status: completed.
02
Drugs
remimazolamdexmedetomidineremifentanil
03
Conditions
localized adiposity (AL)
Beyond the preview
Go deeper on ChiCTR2200062292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062292.